Otezla Cost in 2026: Prices & How to Save
Otezla Cost in 2026: Prices & How to Save
Your dermatologist writes the prescription, you feel hopeful, and then the pharmacy calls with a number that doesn't sound real. Seven thousand dollars. For a month of pills.
That reaction is the correct one. The Otezla cost in the US is genuinely extreme — the average retail cash price runs above $7,000 for a 30-day supply, which works out to roughly $114 per tablet. But the retail price is only one of at least six different numbers you could pay, and the gap between the highest and the lowest is wider than most people realize.
At a glance
- Otezla's list price is $4,830.50 per 30-day supply; average retail cash prices run about $6,843–$7,132
- GoodRx and TrumpRx both land near $3,354 per month — about half of retail, but still over $40,000 a year
- No generic apremilast is sold in the US, and none can launch before February 2028 because of Amgen's patents
- Generic apremilast is available outside the US — through CanAmerica Plus it's $952.99 for 56 tablets (about $17 per tablet)
- Older psoriasis drugs like methotrexate and acitretin cost under $100 a month and are worth asking your doctor about
How much does Otezla cost without insurance in 2026?
Two numbers matter, and they're not the same.
The list price — what Amgen officially charges — is $4,830.50 for a 30-day supply. That's the figure Amgen publishes and the one you'll see quoted in press coverage.
The retail cash price is what a pharmacy actually rings up if you walk in with no insurance and no coupon. As of July 2026 that runs roughly $6,843 to $7,132 for 60 tablets of Otezla 30 mg. SingleCare pegs it at about $114 per tablet. GoodRx puts the average retail price around $7,132.
The retail price is higher than the list price because pharmacies mark up specialty drugs above acquisition cost. Nobody should ever pay that number, and yet people do — usually because they didn't know they had other options.
Annualized, the standard maintenance dose of Otezla (30 mg twice daily) at full retail comes to more than $82,000 a year.
Otezla price comparison: what each channel actually charges
Here's every realistic route to a month of Otezla in the US, with the per-tablet math so you can compare them fairly.
| Where you buy | Cost per month | Cost per tablet |
|---|---|---|
| Retail pharmacy, cash, no coupon | ~$6,843–$7,132 | ~$114–$119 |
| Amgen list price | $4,830.50 | ~$80.51 |
| GoodRx coupon | ~$3,354 | ~$55.90 |
| TrumpRx (most-favored-nation price) | $3,353.93 | ~$55.90 |
| Brand Otezla via CanAmerica Plus | $1,271.99 / 56 tabs | $22.71 |
| Generic apremilast via CanAmerica Plus | $952.99 / 56 tabs | $17.02 |
One thing that trips people up when they compare prices: US packs hold 60 tablets, international packs hold 56. At 30 mg twice daily, 56 tablets is 28 days and 60 tablets is 30 days. A $1,271.99 pack of 56 isn't directly comparable to a $3,354 bottle of 60 unless you do the per-tablet division. That's why the third column exists — it's the only honest way to line these up.
On a per-tablet basis, generic apremilast through a cash-pay network runs about 85% below the US retail cash price and roughly 70% below the GoodRx and TrumpRx price.
Why is Otezla so expensive?
Three reasons, and none of them have to do with what the drug costs to make.
It has no US competition. Apremilast is a small-molecule pill — cheap to manufacture, unlike an injectable biologic. What keeps the price up is patent protection, not chemistry.
The patents hold until 2028. Amgen sued Sandoz and Zydus when they tried to bring generic apremilast to the US market. Amgen won, and the Federal Circuit affirmed that win in April 2023. The controlling patent (US Patent No. 7,427,638, covering apremilast compositions) runs to February 2028. Until then, no generic can legally launch in the United States.
It's priced as a specialty drug. Amgen paid roughly $13.4 billion for Otezla when it bought the drug from Celgene in 2019. That price only made sense at specialty-tier pricing, and Otezla has been priced accordingly ever since. Insurers put it on the highest formulary tier, which is why even insured patients often face a coinsurance percentage rather than a flat copay.
Is there a generic for Otezla?
In the US: no, and there won't be one before February 2028.
Outside the US: yes. Generic apremilast is manufactured and sold in other regulated markets, and it's available through cash-pay networks that source internationally. Through CanAmerica Plus, apremilast is $952.99 for 56 tablets of 30 mg — about $17.02 per tablet, or roughly $1,021 for a 30-day equivalent.
This is the part almost every "how to save on Otezla" article gets wrong. They tell you there's no generic, full stop. That's true of American pharmacy shelves. It is not true of the world.
The brand itself is also available at a fraction of US pricing: brand Otezla through CanAmerica Plus is $1,271.99 for 56 tablets. For comparison, Canadian Pharmacy King lists the same 56-tablet brand pack at $1,501.99.
Savings tip: If you're going the cash-pay route, ask your prescriber to write the prescription for apremilast rather than Otezla by brand. A prescription written for the brand name can't always be filled with the generic. Written generically, it can be filled either way — and you keep the option to take whichever is cheaper that month.
What Otezla costs with insurance and on Medicare
Commercial insurance. Otezla almost always sits on a specialty tier, which usually means coinsurance — a percentage of the drug's cost — rather than a flat copay. Twenty-five percent coinsurance on a $4,830 drug is about $1,208 a month until you hit your out-of-pocket maximum. Prior authorization is standard, and most plans require you to have tried and failed at least one cheaper systemic therapy first.
Medicare Part D. Otezla is covered by most Part D plans, again on a specialty tier. The important change: as of 2026, Medicare Part D out-of-pocket spending is capped at $2,100 per year. Once you hit that ceiling, you pay $0 for covered Part D drugs for the rest of the calendar year. For a drug like Otezla, most people will blow through $2,100 in the first month or two — which means the practical annual cost for a Medicare patient on Otezla is roughly $2,100, not $58,000.
That cap is the single most useful thing to know if you're on Medicare and staring at a specialty-tier quote. It doesn't lower the monthly bill in January. It does put a hard ceiling on the year.
Medicaid. Coverage varies by state, and prior authorization is near-universal.
Cheaper alternatives worth discussing with your doctor
Otezla isn't the only systemic option for plaque psoriasis or psoriatic arthritis, and some of the alternatives cost less than a restaurant dinner. They are not interchangeable with Otezla — they work by different mechanisms, carry different risks, and require different monitoring. But if cost is the barrier between you and any treatment, these are worth raising.
| Medication | Cash-pay price | Notes |
|---|---|---|
| Methotrexate 2.5 mg | $65.99 / 100 tabs | Decades of use in psoriasis and PsA. Requires regular blood work; not for use in pregnancy. |
| Acitretin 10 mg | $79.99 / 60 caps | Oral retinoid for severe psoriasis. Strict contraception requirements; monitors liver and lipids. |
| Cyclosporine | Varies by strength | Fast-acting but generally used short-term; affects kidney function and blood pressure. |
| Humira | Varies | Injectable biologic. Different mechanism and stronger for some patients; different risk profile. |
| Rinvoq | Varies | Oral JAK inhibitor. Carries boxed warnings; typically used after other therapies. |
Methotrexate at $65.99 for 100 tablets is not a marketing gimmick. It's a genuinely effective drug for a lot of people with psoriasis and psoriatic arthritis, and for some patients it works as well as Otezla for about 1% of the cost. It also has real downsides — the blood monitoring is non-negotiable, the pregnancy risks are serious, and some people can't tolerate it. Your dermatologist or rheumatologist is the right person to sort out whether it fits.
Don't switch or stop anything on your own. But do bring the price up. Most prescribers have no idea what you're being charged at the counter, and many will happily reconsider once they know.
Practical ways to bring your Otezla cost down
Ask what your plan's specialty tier actually charges. Coinsurance percentages vary a lot. Call the number on your insurance card and ask for the exact dollar amount before you fill.
Compare per-tablet, not per-pack. Pack sizes differ across channels. Per-tablet is the only comparison that means anything.
Check whether generic apremilast is an option for you. It's the cheapest legitimate route in the table above, and it's the same molecule.
If you're on Medicare, plan around the $2,100 cap. Your worst months are the early ones. After that, the year is capped.
Ask about a cheaper systemic first. If methotrexate or acitretin would work for you clinically, the savings are enormous — and many insurers require you to try one anyway.
Verify the pharmacy. Any cash-pay route should route through a licensed, verified pharmacy. If a website offers a prescription drug without requiring a prescription, that's a signal to walk away.
The bottom line
Otezla costs about $4,830 at list and up to $7,132 at retail, and no US generic can arrive before February 2028. GoodRx and TrumpRx both cut that roughly in half. Cash-pay routes go considerably further — generic apremilast lands near $17 a tablet versus $114 at a US pharmacy counter.
Two next steps: check the price on Otezla and apremilast against whatever your pharmacy quoted you, and ask your prescriber whether a cheaper systemic therapy would work as well for your case. Both conversations are worth having before you pay a specialty-tier bill you don't have to.
Frequently asked questions
How much does a 30-day supply of Otezla cost?
At a US retail pharmacy with no insurance and no coupon, roughly $6,843 to $7,132. The manufacturer's list price is $4,830.50. With a GoodRx coupon or through TrumpRx, about $3,354. Through cash-pay channels, the equivalent 30-day cost drops to roughly $1,000–$1,360 depending on whether you're taking brand or generic.
Why is Otezla so expensive?
Patent protection, not manufacturing cost. Apremilast is an inexpensive pill to produce, but Amgen holds US patents through February 2028 and successfully blocked Sandoz and Zydus from launching generics. Amgen also paid about $13.4 billion for the drug in 2019, and prices it as a specialty product.
Is there a generic version of Otezla?
Not in the United States, and not before February 2028. Generic apremilast is made and sold in other regulated markets, and cash-pay networks that source internationally can supply it — CanAmerica Plus lists it at $952.99 for 56 tablets.
Does Medicare cover Otezla?
Most Part D plans cover it on a specialty tier with prior authorization. In 2026, Part D out-of-pocket spending is capped at $2,100 for the year, so a Medicare patient on Otezla will generally hit that ceiling early and pay nothing further for covered drugs after that.
Is Otezla cheaper from Canada or other countries?
Substantially. Brand Otezla runs $1,271.99 for 56 tablets through CanAmerica Plus and $1,501.99 through Canadian Pharmacy King, against $3,354–$7,132 for a comparable US supply. Generic apremilast, unavailable in US pharmacies, is cheaper still. Use only licensed, verified pharmacies, and expect to provide a valid prescription.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.
